Humatica’s new whitepaper on Buy & Build. Download now

closeicon

Humatica’s new whitepaper on Buy & Build. Download now

closeicon

Humatica advises the Riverside Company on their recent investment in Alter Pharma

ndetails

Humatica Ltd. was retained to advise the Riverside Company on its investment in Alter Pharma, a Belgian pharmaceutical group. Alter Pharma distributes EU-sourced pharmaceutical products to wholesalers pharmacies and hospitals. It also develops and reformulates generic pharmaceuticals using GMP approved third-party manufacturers, and sells them internationally through partnerships

Humatica provided organisational due diligence services for this transaction.

To view press release: Humatica Advisor to Riverside for AlterPharma

Related News

Four Consultants Promoted in Humatica’s London and Zurich Offices
06 Sep, 2021 By Humatica

Four Consultants Promoted in Humatica’s London and Zurich Offices

Humatica, the leading private equity specialist advisor for portfolio organizational effectiveness, is proud to announce four promotions in its London and Zurich offices. Paul Simpson…

Read more arrowicon
Humatica moves to larger offices in London Soho
03 Sep, 2021 By Humatica

Humatica moves to larger offices in London Soho

We are proud to announce that following our record growth in 1H 2021, Humatica has moved to new and larger offices in central London. Andros…

Read more arrowicon
Valentina Pozzobon appointed as CFO of SAMP
01 Sep, 2021 By Humatica

Valentina Pozzobon appointed as CFO of SAMP

Valentina Pozzobon, a Director and Board Member of Humatica, the leading private equity specialist advisor for portfolio company organisational effectiveness, will take a full-time role…

Read more arrowicon